Brad Vale is a founding general partner at Treo Ventures, a venture capital firm that invests in medical devices. See sector focus and contact routes.
Brad Vale is a founding general partner at Treo Ventures, a venture capital firm that invests in medical devices and digital health innovations targeting large unmet clinical needs across early-stage (pre-seed to Series A) and later-stage companies with demonstrated feasibility or clinical data. His notable portfolio includes board seats at Hyalex Orthopaedics, InterVene (where he joined the board after Treo co-led its $13M Series A), and ShiraTronics, plus prior investment in Nevro before its IPO. Vale’s distinctive thesis centers on leveraging deep Big Medtech operational experience to fund solutions in conventional implantable devices and neuromodulation, often supplemented by Treo’s NuXcel medical device accelerator to nurture novel technologies.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in United States when building a target list.
Investors like Brad Vale · Full investor directory · Investor access · Company funding database